News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
153 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (28606)
Month
January (2488)
February (2603)
March (3227)
April (2950)
May (3962)
June (3500)
July (2854)
August (3141)
September (3205)
October (3539)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (215)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Deals
Exactech Goes Private in $625M Deal With TPG Capital
TPG Capital has acquired all the outstanding shares of Exactech common stock for $42 per share.
October 23, 2017
·
2 min read
·
Alex Keown
Pharm Country
The 5 Key Drugs That Need to Keep Performing to Keep Johnson & Johnson on Top
If J&J’s going to keep rewarding investors, it’s going to need these top drugs to continue racking up sales.
October 23, 2017
·
1 min read
Deals
Week in Review: WuXi AppTec Acquires US-Global Clinical CRO
WuXi AppTec, a China CRO/CMO, will acquire ResearchPoint Global, of Texas, a global clinical-stage contract research company, to extend the reach of its own clinical CRO coverage.
October 23, 2017
·
1 min read
Career Advice
Tips on How to Get Hired From Roche
Here is how you can land a job at one of the biggest pharmaceuticals in the world.
October 23, 2017
·
4 min read
·
Mark Terry
Drug Development
Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S.
Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team.
October 23, 2017
·
4 min read
·
Alex Keown
Drug Development
Amgen’s KYPROLIS Meets Goals in Phase III Multiple Myeloma Study
A late-stage study shows that a stronger weekly dose of Amgen’s Kyprolis combined with dexamethasone had a greater progression-free survival benefit than a twice-weekly dose of the drug at the approved dosing level.
October 23, 2017
·
2 min read
·
Alex Keown
Drug Development
Mis-Matched Expectations With Celgene, Ionis
The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced.
October 23, 2017
·
1 min read
·
Karl Thiel
Business
Scott Gottlieb’s Meteoric Rise?
A look at FDA head Scott Gottlieb’s career so far.
October 23, 2017
·
1 min read
·
Karl Thiel
Business
George Scangos’ Bold Vision
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
October 23, 2017
·
1 min read
·
Karl Thiel
Biotech Bay
Shhhh.....There’s a New T-Cell Strategy
Rumor is there’s a new approach to fighting cancer in town.
October 23, 2017
·
1 min read
·
Karl Thiel
Previous
15 of 16
Next
